Zurn Elkay (ZWS) Q1 2026 Earnings Transcript

Zurn Elkay reported strong Q1 results with 11% organic/core sales growth to $433 million, adjusted EBITDA up 18% to $116 million, and margin expansion of 160 bps to 26.8%. The company generated $43 million of free cash flow, repurchased $50 million of stock, and ended with net debt leverage of just 0.5x after upsizing its revolver to $550 million. Management reiterated Q2 guidance for 8%-9% core sales growth and 27%-27.5% EBITDA margin, while keeping full-year guidance conservative amid tariff uncertainty.

Analysis

ZWS is quietly turning tariff volatility into a competitive advantage. The important second-order effect is not just pricing power, but sourcing optionality: as more of the bill of materials shifts domestically and the company exits low-margin residential SKUs, tariff shocks become less of a margin headwind than a relative moat versus peers that still rely on imported components or more commodity-like distribution relationships. That should widen share gains in spec-driven channels where contractors and engineers prefer less disruption, especially if competitors need to re-trade pricing later in the year.

The bigger structural story is that the business is moving from a cyclical industrial name to a compounding installed-base and retrofit story. Retrofit/replace reaching parity with new construction means growth should become less hostage to housing starts and more tied to replacement cadence, water-safety regulation, and facility upgrade budgets; if that mix drifts toward the mid-50s as management hinted, the revenue base becomes materially more resilient. The implication is multiple expansion potential, because investors tend to pay up for recurring replacement demand with visible attach rates, while still underestimating how much incremental margin comes from product mix rather than pure cost cuts.

Catalyst risk is timing: the stock can stall if Q2 confirms strong execution but management continues to defer full-year upside until later in the summer. Near term, the main failure mode is not demand collapse but pricing fatigue in residential and any delay in converting the drinking-water/specification wins into broader commercial share. Over the next 1-2 quarters, the key tell will be whether margin stays above 27% while growth broadens beyond weather and pricing; if not, the market will reclassify this as a one-quarter beat rather than a durable re-rate story.

The contrarian read is that consensus may be underestimating the durability of operating leverage. The market is likely anchoring on tariff noise and treating the guidance pause as cautionary, but management appears to have built enough supply-chain flexibility that incremental tariffs are more of a relative advantage than a threat. If they execute even modestly on M&A or a new adjacency launch, the multiple could reset higher because investors will start capitalizing a more diversified, higher-retention platform rather than a plumbing fixtures supplier.

Key Decisions for Investors

• Long ZWS on any post-earnings digestion or broader industrial weakness; 3-6 month horizon with upside from a margin-led re-rating if Q2 confirms >27% EBITDA margin and no guidance cut.
• Pair trade: long ZWS / short a more tariff-exposed building-products or plumbing peer with higher import dependence; thesis is relative margin outperformance as domestic sourcing becomes a moat over 2-4 quarters.
• Buy ZWS call spreads 3-6 months out rather than outright calls to express upside from a late-summer guidance reset while capping theta if management stays deliberately conservative.
• For risk-controlled longs, use a stop if the next print shows margin compression below the guided 27% range or if retrofit/replace mix stalls below 50/50; those would signal the mix thesis is not inflecting.
• If looking for a catalyst trade, add ahead of Q2 only on weakness: the setup favors a beat-and-hold, not a blowup, because the business appears to be compounding even in a soft residential backdrop.